The event aims to introduce and explore APTAMARKER, an advanced aptamer-based technology platform developed by Dr. Gregory Penner and his team at Neoventures Biotechnology. This platform represents a transformative approach to biomarker discovery and precision medicine through the integration of mathematical modeling, AI & deep data analysis, and molecular profiling.

The session will begin with an overview of the APTAMARKER technology, covering its core principles, workflows, and data analysis strategies. This will provide participants with a comprehensive understanding of how the platform operates and its scientific foundation.

The second part of the event will focus on the current and emerging applications of APTAMARKER in clinical research, including:

• Biomarker discovery and validation
• Proteoform analysis and its significance in understanding disease heterogeneity and mechanisms
• Phenotyping and patient stratification

By the end of the session, participants will gain insights into how APTAMARKER can enhance translational research, support clinical decision-making, and accelerate the discovery of precision biomarkers across various diseases.

The overall objective is to foster knowledge exchange between technology developers, researchers, and clinicians, and to explore potential collaborations leveraging aptamer-based technologies for advancing biomarker discovery and precision medicine.

For more information on this program and schedule, visit Sidra Medicine Masterclass